VANECK VECTORS ETF TR's ticker is GDX and the CUSIP is 92189F106. A total of 403 filers reported holding VANECK VECTORS ETF TR in Q3 2018. The put-call ratio across all filers is 1.55 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $816,450 | -19.1% | 30,340 | -9.5% | 0.00% | +100.0% |
| Q2 2023 | $1,009,588 | -84.3% | 33,530 | -13.5% | 0.00% | -85.7% |
| Q1 2023 | $6,449,134 | +1150.8% | 38,780 | +115.6% | 0.01% | +250.0% |
| Q4 2022 | $515,593 | +42.0% | 17,990 | +19.6% | 0.00% | +100.0% |
| Q3 2022 | $363,000 | -35.8% | 15,045 | -27.0% | 0.00% | 0.0% |
| Q2 2022 | $565,000 | -46.0% | 20,617 | -24.5% | 0.00% | -50.0% |
| Q1 2022 | $1,046,000 | +63.2% | 27,300 | +36.4% | 0.00% | +100.0% |
| Q4 2021 | $641,000 | -41.2% | 20,015 | -45.9% | 0.00% | -66.7% |
| Q3 2021 | $1,090,000 | -16.0% | 36,996 | -3.1% | 0.00% | 0.0% |
| Q2 2021 | $1,298,000 | +30.1% | 38,198 | +24.3% | 0.00% | 0.0% |
| Q1 2021 | $998,000 | -15.4% | 30,725 | -6.2% | 0.00% | 0.0% |
| Q4 2020 | $1,180,000 | -10.7% | 32,750 | -2.9% | 0.00% | -25.0% |
| Q3 2020 | $1,321,000 | +70.2% | 33,720 | +59.4% | 0.00% | 0.0% |
| Q2 2020 | $776,000 | -1.0% | 21,151 | -37.8% | 0.00% | +33.3% |
| Q1 2020 | $784,000 | +32.9% | 33,989 | +68.6% | 0.00% | +50.0% |
| Q4 2019 | $590,000 | +12.4% | 20,158 | +2.5% | 0.00% | 0.0% |
| Q3 2019 | $525,000 | +4.4% | 19,671 | 0.0% | 0.00% | 0.0% |
| Q2 2019 | $503,000 | +14.1% | 19,671 | 0.0% | 0.00% | 0.0% |
| Q1 2019 | $441,000 | +43.6% | 19,671 | +35.2% | 0.00% | +100.0% |
| Q4 2018 | $307,000 | -10.5% | 14,545 | -21.6% | 0.00% | 0.0% |
| Q3 2018 | $343,000 | -31.0% | 18,545 | -16.9% | 0.00% | -50.0% |
| Q2 2018 | $497,000 | -30.3% | 22,305 | -31.2% | 0.00% | -33.3% |
| Q1 2018 | $713,000 | +21.3% | 32,440 | +28.3% | 0.00% | +50.0% |
| Q4 2017 | $588,000 | -4.2% | 25,290 | -5.5% | 0.00% | -33.3% |
| Q3 2017 | $614,000 | +91.3% | 26,757 | +84.0% | 0.00% | +50.0% |
| Q2 2017 | $321,000 | -3.3% | 14,545 | 0.0% | 0.00% | 0.0% |
| Q1 2017 | $332,000 | +9.2% | 14,545 | 0.0% | 0.00% | 0.0% |
| Q4 2016 | $304,000 | -20.8% | 14,545 | 0.0% | 0.00% | -33.3% |
| Q3 2016 | $384,000 | -4.7% | 14,545 | 0.0% | 0.00% | 0.0% |
| Q2 2016 | $403,000 | – | 14,545 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Memorial Sloan Kettering Cancer Center | 738,500 | $20,220,000 | 66.82% |
| Baymount Management LP | 145,000 | $3,970,000 | 28.08% |
| New Harbor Financial Group, LLC | 1,371,341 | $37,547,000 | 18.51% |
| New Harbor Financial Group, LLC | 1,291,700 | $35,366,000 | 17.44% |
| MKP Capital Management, L.L.C. | 1,500,000 | $41,070,000 | 13.74% |
| Windmill Hill Asset Management Ltd | 844,600 | $23,125,000 | 11.94% |
| Hollow Brook Wealth Management LLC | 768,567 | $21,043,000 | 11.57% |
| Grand Central Investment Group | 261,915 | $7,171,000 | 10.33% |
| Point72 Europe (London) LLP | 1,467,000 | $40,166,000 | 8.50% |
| Slate Path Capital LP | 4,600,000 | $125,948,000 | 7.87% |